Health Catalyst (HCAT) Tops Q3 EPS by 10c, Revenues Beat; Offers FY19 Revenue Guidance Above Consensus
Tweet Send to a Friend
Health Catalyst (NASDAQ: HCAT) reported Q3 EPS of ($0.27), $0.10 better than the analyst estimate of ($0.37). Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
